Net worth tracking
Login Sign Up
  • All Opinions
  • Top Picks
  • Discover
  • Companies
  • Experts
WATCH LIST
Home » Daily

Markets rally on positive drug treatment tests

Allan TongAllan Tong Posted On April 29, 2020
0
449 Views
0
0
Shares
  • Share On Facebook
  • Tweet It

Markets rallied Wednesday after hearing news of positive test results of Gilead‘s remdesivir‘s drug treatment COVID-19 patients. Though more testing is needed before remdesivir can be used anywhere, the hopeful news lifted markets. Gildea stock spiked 5.7%. In fact, indices in Toronto and New York kept rising throughout the session, with the Nasdaq jumping 3.57% and the TSX rising 2.9%. A barrel of WTI soared 25% and WCS by 45%. Countries continue to plan gradual reopenings, but so are major retailers like Best Buy, which announced it will allow customers into selected stores by appointment.

In Toronto, the risk-in sentiment propelled the energy sector over 13% higher, including Crescent Point and Baytex, which both surged more than 17%. Financials also rallied with all the big banks gaining, such as BMO by 5%. Loblaw released its quarterly report, beating the street in profit, but warned that “unprecedented” demand has been moderating since late March when consumers were stockpiling goods in panic. Loblaw actually closed down 3.84%.

On Wall Street, the optimism overshadowed news that that U.S. GDP plunged 4.8% in Q1, its biggest drop since 2008. Meanwhile, the U.S. Fed held interest rates near zero. In a day of winners, one of the biggest was Google, soaring 8.74% on a Q1 revenue beat.

🧫 Gilead Sciences Inc. +5.70%
🛢 Crescent Point Energy Corp +17%
🛢 Baytex Energy Corp +17%
🏛 Bank of Montreal +5%
🛒 Loblaw Companies Ltd -3.84%
🅰 Alphabet Inc. / Google +8.74%

Post Views: 449
0
Shares
  • Share On Facebook
  • Tweet It




Trending Now
Fortis Inc., Power Corp and More at 52-week Highs (Apr 07-13)
Melisa R. H. April 14, 2021
Stride, Inc., Chubb Limited and 20 Stock and 1 ETF Top Picks (Apr 09-15)
Melisa R. H. April 16, 2021
Read Next

TSX reverses gains as Wall Street sells off on grim news

  • We're the Stock Chasers
    Hi! We are the Stock Chasers. We write about investing and finance tools we love. We’re passionate about fintech and we invest almost all our affiliate and advertising revenues into the development of Stockchase and Wealthica. We hope you enjoy the stock ideas and product reviews!
  • Join 39,652 Investors

    Winning in the Market eBook
    We deliver stock ideas to your inbox. Sign up free, get the ebook!

  • Top Reviews

    • The Ugly Truth About Identity Theft – Free Credit Report
      10
    • Questrade Review: Pros & Cons of Trading with Questrade Canada (2021)
      8.5
    • Questrade vs Others | The Review Competitors Don’t Want you to Read (2021)
      7.4
  • Popular Posts

    • Fortis Inc., Power Corp and More at 52-week Highs (Apr 07-13)
    • Stride, Inc., Chubb Limited and 20 Stock and 1 ETF Top Picks (Apr 09-15)
    • Rogers Communications (B), Canadian Pacific Rail and More Earnings Reports this Week (Apr 19-23)
    • 3 Underestimated Automation Stocks
    • Wine and Pizza: 3 Uplifting Food Stocks
  • Stock Lists

    • 3 Promising Stock Upgrades: SNAP, Uber, Corus
      April 13, 2021
    • April Showers and Flowers: 4 Covid Vaccination Stocks...
      April 6, 2021
    • Wine and Pizza: 3 Uplifting Food Stocks
      March 30, 2021
    • 3 Underestimated Automation Stocks
      March 23, 2021
    • 5G Stocks Are Coming -- Are You Ready?
      March 16, 2021


  • Get $50 in free trades.


  • Stockchase neither recommends nor promotes any investment strategies.

    About us : Privacy & Terms : Contact us

© Stockchase Inc.
Press enter/return to begin your search